Treatment of androgen deficiency in the aging male

    Insights

    Androgen replacement therapy guidelines exist for older men, but limited clinical trials show it

    Area of Science:

    • Gerontology
    • Endocrinology
    • Men's Health

    Background:

    • Aging is associated with declining testosterone levels in men.
    • Existing guidelines for androgen replacement therapy (ART) in older men are based on limited clinical trial data.
    • The clinical significance of testosterone decline in aging men remains unclear.

    Purpose of the Study:

    • To evaluate the evidence supporting androgen replacement therapy in older men.
    • To determine if testosterone decline in aging men constitutes an androgen deficient state.
    • To assess the impact of ART on health-related outcomes in aging men.

    Main Methods:

    • Review of existing clinical trials on androgen replacement therapy.
    • Analysis of data supporting current treatment guidelines.
    • Assessment of the link between testosterone decline and health outcomes.

    Main Results:

    • The evidence base for ART guidelines in older men is derived from a small number of clinical trials.
    • A definitive androgen deficient state due to testosterone decline in aging men has not been established.
    • Improvements in health-related outcomes with ART have not been definitively proven.

    Conclusions:

    • Current guidelines for androgen replacement therapy in older men lack robust supporting data.
    • Further research is needed to establish the efficacy and necessity of ART for aging men.
    • The health benefits of treating testosterone decline in older men require further investigation.

    Related Concept Videos

    Disorders of the Male Reproductive System01:20

    Disorders of the Male Reproductive System

    Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
    Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
    Menopause01:28

    Menopause

    Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
    Bone Disorders01:29

    Bone Disorders

    Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
    Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
    Infertility in Males01:23

    Infertility in Males

    Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
    Alzheimer's Disease: Treatment01:22

    Alzheimer's Disease: Treatment

    Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
    The Effect of Aging on Tissues01:19

    The Effect of Aging on Tissues

    Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...